Trademarkia Logo

Australia

AU$
AKAFTREO
Cancelled: Cancelled at the request of IB

Last updated on 23 Nov 2022

Owner Info

Vertex Pharmaceuticals Incorporated

50 Northern Avenue

Boston MA 02210, UNITED STATES OF AMERICA

Serial Number

1965980 filed on 18 Sept 2018

Correspondent

Timothy H. Hiebert

Womble Bond Dickinson (US) LLP,

470 Atlantic Avenue, Suite 600,

UNITED STATES OF AMERICA

AKAFTREO

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of cystic fibrosis

Mark Details


Serial Number

1965980

Registered On

18 Sept 2018

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

29 Mar 2018

Mark Type

US

Legal History


Show more

Status DateAction Taken
23rd Nov 2022Status change to Voided
30th Jul 2020Amendment to International Registration Contact Requested
25th Jun 2019International Registration in Australia Protected correspondence sent
24th Jun 2019IP Right Registration Published
24th Jun 2019Status change to Registered/Protected
16th Apr 2019Application Accepted correspondence sent
16th Apr 2019IP Right Acceptance Published
16th Apr 2019IP Right has been Examined
16th Apr 2019Status change to Accepted
8th Nov 2018IP Right Filed Published